Jiangsu Hengrui Medicine Co., Ltd
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1970-01-01
- Employees
- -
- Market Cap
- $38.9B
The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers
- First Posted Date
- 2016-07-07
- Last Posted Date
- 2016-07-07
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02826044
- Locations
- π¨π³
the First Hosital of Jilin University, Changchun, Jilin, China
The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02822534
- Locations
- π¨π³
the First Hosital of Jilin University, Changchun, Jilin, China
the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy Volunteers
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02821871
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
The DDI Study of SP2086 and Simvastatin
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02817243
- Locations
- π¨π³
the First Hosital of Jilin University, Changchun, Jilin, China
The DDI Study of SP2086 and Valsartan
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02817217
- Locations
- π¨π³
People's Liberation Army General Hospital of Chengdu Military Region, Chengdu, Sichuan, China
Single Dose Study of SHR4640 in Healthy Subjects
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2017-02-28
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT02815839
- Locations
- π¨π³
Southwest Hospital, Chongqing, Sichuan, China
The Drug-drug Interaction of SP2086 and Valsartan
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02815657
- Locations
- π¨π³
People's Liberation Army General Hospital of Chengdu Military Region, Chengdu, China
SP2086 Pharmacokinetic Study in Renal Insufficiency Patients
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02815774
The Drug -Drug Interaction of SP2086 and Glyburide
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02815787
- Locations
- π¨π³
Qilu Hospital of Shandong University, Jinan, Shandong, China
The Metabolite Identification and Material Balance Study of SP2086
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT02815748
Β© Copyright 2024. All Rights Reserved by MedPath